Yayınlar & Eserler

Yayın Ağı
Makaleler 53
Tümü (53)
SCI-E, SSCI, AHCI (47)
SCI-E, SSCI, AHCI, ESCI (49)
ESCI (2)
Scopus (52)
TRDizin (9)

1. Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices

GEZGİN YILDIRIM D., Orulluoglu E. Y., Yildiz C., AÇARI C., Dundar H. A., Akaci O., et al.
Pediatric Rheumatology , cilt.23, sa.1, 2025 (SCI-Expanded) identifier identifier

2. Exploring gastrointestinal manifestations in childhood onset systemic lupus erythematosus - Insights from a multicenter study

Sönmez H. E., Batu E. D., İşgüder R., Şahin N., Aliyev E., Aslan E., et al.
Lupus , cilt.33, sa.12, ss.1358-1364, 2024 (SCI-Expanded) identifier identifier

3. Pediatric Behçet’s disease

KAYA AKCA Ü., BİLGİNER Y.
Trends in Pediatrics , cilt.5, sa.3, ss.53-59, 2024 (Scopus) identifier

4. A rare disease with many faces: A multicenter registry of IgG4-related disease in children.

Kaya Akca Ü., Kose H., Kurt T., Ulu K., Guliyeva V., Kılbas G., et al.
Rheumatology (Oxford, England) , 2024 (SCI-Expanded) identifier

5. Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children

Kaya Akca U., BATU AKAL E. D., Jelusic M., Calatroni M., Bakry R., Frkovic M., et al.
Rheumatology (United Kingdom) , cilt.63, sa.SI2, 2024 (SCI-Expanded) identifier identifier

6. Drug-induced lupus erythematosus in childhood: Case-based review

KAYA AKCA Ü., Sener S., BATU AKAL E. D., BALIK Z., BAŞARAN H. Ö., BİLGİNER Y., et al.
Lupus , cilt.33, sa.7, ss.737-748, 2024 (SCI-Expanded) identifier identifier

7. Thrombotic manifestations in pediatric Behcet syndrome: A multicenter comparative study from the EUROFEVER registry

Mastrolia M. V., Matucci-Cerinic C., ÖZEN S., KASAPÇOPUR Ö., Gaggiano C., Koné-Paut I., et al.
Seminars in Arthritis and Rheumatism , cilt.66, 2024 (SCI-Expanded) identifier identifier

8. Rhupus syndrome in children: A multi-center retrospective cohort study and literature review

Sener S., BATU AKAL E. D., Sahin S., Yildirim D. G., Ekinci M. K., Kisaoglu H., et al.
Lupus , cilt.33, sa.3, ss.273-281, 2024 (SCI-Expanded) identifier identifier

9. Differentiating Multisystem Inflammatory Syndrome in Children from Kawasaki Disease During the Pandemic

Şener S., BATU AKAL E. D., KAYA AKCA Ü., Atalay E., Cüceoğlu M. K., BALIK Z., et al.
Turkish Archives of Pediatrics , cilt.59, sa.2, ss.150-156, 2024 (ESCI) identifier identifier

10. Transition of patients with systemic lupus erythematosus from pediatric to adult-oriented rheumatology care

Şener S., Yardimci G. K., BATU AKAL E. D., KILIÇ L., KAYA AKCA Ü., Cüceoğlu M. K., et al.
Turkish Journal of Medical Sciences , cilt.54, sa.6, ss.1198-1204, 2024 (SCI-Expanded) Creative Commons License identifier

11. Chronic non-bacterial osteomyelitis and immune checkpoint molecules

KAYA AKCA Ü., SAĞ E., Aydın B., Tasdemir N. K., Kasap Cuceoglu M., BAŞARAN H. Ö., et al.
Clinical Rheumatology , cilt.43, sa.1, ss.553-560, 2024 (SCI-Expanded) identifier identifier

12. Evaluation of clinical outcomes in systemic juvenile idiopathic arthritis patients treated with biological agents in Turkey: The TURSIS study

Sozeri B., Demir F., Barut K., Atalay E., Pac Kisaarslan A., Ozdel S., et al.
Clinical and Experimental Rheumatology , cilt.42, sa.1, ss.194-201, 2024 (SCI-Expanded) identifier identifier

13. Feasibility of Conducting Comparative Effectiveness Research and Validation of a Clinical Disease Activity Score for Chronic Nonbacterial Osteomyelitis

Wu E. Y., Oliver M., Scheck J., Lapidus S., KAYA AKCA Ü., Yasin S., et al.
Journal of Rheumatology , cilt.50, sa.10, ss.1333-1340, 2023 (SCI-Expanded) identifier identifier

14. The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study †

BAŞARAN H. Ö., BATU AKAL E. D., KAYA AKCA Ü., Atalay E., Kasap Cuceoglu M., Sener S., et al.
Children , cilt.10, sa.6, 2023 (SCI-Expanded) identifier identifier

15. Correspondence on 'Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine-learning-based model to assist the diagnosis of systemic lupus erythematosus'

BATU AKAL E. D., KAYA AKCA Ü., BAŞARAN H. Ö., BİLGİNER Y., ÖZEN S.
Annals of the Rheumatic Diseases , cilt.82, sa.6, 2023 (SCI-Expanded) identifier identifier

16. The Characteristics of Patients With COVID-19–Associated Pediatric Vasculitis: An International, Multicenter Study

Batu E. D., Sener S., Ozomay Baykal G., Arslanoglu Aydin E., Özdel S., Gagro A., et al.
Arthritis and Rheumatology , cilt.75, sa.4, ss.499-506, 2023 (SCI-Expanded) identifier identifier

17. Report of 2 pediatric cases with atypical Cogan's syndrome and a systematic review

Kasap Cuceoglu M., BAŞARAN H. Ö., BATU AKAL E. D., KAYA AKCA Ü., Atalay E., Sener S., et al.
International Journal of Rheumatic Diseases , cilt.26, sa.3, ss.544-550, 2023 (SCI-Expanded) identifier identifier

18. A new tool supporting the diagnosis of childhood-onset Behçet's disease: venous wall thickness

Atalay E., OĞUZ B., Sener S., ÖZCAN H. N., SAĞ E., KAYA AKCA Ü., et al.
Rheumatology (United Kingdom) , cilt.62, sa.SI2, 2023 (SCI-Expanded) identifier identifier

19. The impact of illness perception on medication adherence in pediatric patients with familial Mediterranean fever

KAYA AKCA Ü., Barış S., Öztürk H.
Trends in Pediatrics , cilt.4, sa.3, ss.147-154, 2023 (Scopus) identifier

20. Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods.

Kaya Akca Ü., Batu E. D., Tanalı G., Atalay E., Kasap Cüceoğlu M., Sener S., et al.
Turkish archives of pediatrics , cilt.58, sa.1, ss.49-55, 2023 (ESCI) identifier

21. Poor performance of IgG4-related disease responder index in children

KAYA AKCA Ü., Yardimci G., BİLGİNER Y., ÖZEN S., KARADAĞ Ö.
Clinical and Experimental Rheumatology , cilt.40, sa.12, ss.2463, 2022 (SCI-Expanded) identifier identifier

22. Treatment of childhood-onset Takayasu arteritis: Switching between anti-TNF and anti-IL-6 agents

Sener S., BAŞARAN H. Ö., KAYA AKCA Ü., Atalay E., Kasap Cuceoglu M., Balik Z., et al.
Rheumatology (United Kingdom) , cilt.61, sa.12, ss.4885-4891, 2022 (SCI-Expanded) identifier identifier

23. The difference of the inflammatory milieu in MIS-C and severe COVID-19

Gurlevik S. L., ÖZSÜREKCİ Y., SAĞ E., Derin Oygar P., KESİCİ S., KAYA AKCA Ü., et al.
Pediatric Research , cilt.92, sa.6, ss.1805-1814, 2022 (SCI-Expanded) identifier identifier

24. Challenges in diagnosing COVID-19 related disease in pediatric patients with rheumatic disease

Sener S., BAŞARAN H. Ö., Gurlevik S. L., KAYA AKCA Ü., Atalay E., Cuceoglu M. K., et al.
Modern Rheumatology , cilt.32, sa.6, ss.1108-1113, 2022 (SCI-Expanded) identifier identifier

25. The challenges in diagnosing pediatric primary antiphospholipid syndrome

DEMİR S., Keskin A., SAĞ E., KAYA AKCA Ü., Atalay E., Cüceoğlu M. K., et al.
Lupus , cilt.31, sa.10, ss.1269-1275, 2022 (SCI-Expanded) identifier identifier

26. IgG4-related disease in pediatric patients: a single-center experience

KAYA AKCA Ü., Atalay E., Kasap Cüceoğlu M., Şener S., BALIK Z., BAŞARAN H. Ö., et al.
Rheumatology International , cilt.42, sa.7, ss.1177-1185, 2022 (SCI-Expanded) identifier identifier

27. The Asthma Risk Is Increased in Children with Severe Allergic Rhinitis

Akca Ü., Maslak İ. C., Uygun D., BİNGÖL A.
Turkish Archives of Pediatrics , cilt.57, sa.4, ss.391-397, 2022 (Scopus) identifier identifier

28. Probiotic use in the prophylaxis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a retrospective cohort study

BATU AKAL E. D., KAYA AKCA Ü., BAŞARAN H. Ö., BİLGİNER Y., ÖZEN S.
Rheumatology International , cilt.42, sa.7, ss.1207-1211, 2022 (SCI-Expanded) identifier identifier

29. The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study

KAYA AKCA Ü., BATU AKAL E. D., Sener S., BALIK Z., Kasap Cuceoglu M., Atalay E., et al.
Clinical Rheumatology , cilt.41, sa.6, ss.1785-1792, 2022 (SCI-Expanded) identifier identifier

30. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study

Sozeri B., Ulu K., KAYA AKCA Ü., Haslak F., Pac-Kisaarslan A., Otar-Yener G., et al.
Rheumatology International , cilt.42, sa.3, ss.469-475, 2022 (SCI-Expanded) identifier identifier

31. Clinical course of COVID-19 infection in paediatric familial Mediterranean fever patients

KAYA AKCA Ü., Sener S., Ballk Z., Gurlevik S., Oygar P. D., Atalay E., et al.
Modern Rheumatology , cilt.32, sa.2, ss.467-472, 2022 (SCI-Expanded) identifier identifier

32. Comparison of IVIG resistance predictive models in Kawasaki disease

KAYA AKCA Ü., Arslanoglu Aydin E., AYKAN H. H., Serin O., SAĞ E., DEMİR S., et al.
Pediatric Research , cilt.91, sa.3, ss.621-626, 2022 (SCI-Expanded) identifier identifier

33. The Comparison of Pediatric Patients with Familial Mediterranean Fever Originated from Turkey and Crimea

Kostik M., Kaya Ü., Zhogova O. V., Sag E., Suspitsin E. N., Nizhnik V. I., et al.
Turkish Archives of Pediatrics , cilt.57, sa.5, ss.551-557, 2022 (Scopus) identifier identifier

34. Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases

KAYA AKCA Ü., Atalay E., Cuceoglu M. K., BALIK Z., Sener S., ÖZSÜREKCİ Y., et al.
Rheumatology International , cilt.42, sa.1, ss.51-57, 2022 (SCI-Expanded) identifier identifier

35. Two siblings with Majeed syndrome and neutropenia

Kasap Cuceoglu M., BATU AKAL E. D., YILDIZ A. E., KAYA AKCA Ü., Atalay E., Sener S., et al.
Archives of Rheumatology , cilt.37, sa.4, ss.638-640, 2022 (SCI-Expanded) Creative Commons License identifier

36. Real-world data on MTX tolerance with regimens used in children versus adults

KAYA AKCA Ü., Farisogullari B., Yardimci G. K., SAĞ E., Atalay E., Kasap Cuceoglu M., et al.
Clinical Rheumatology , cilt.40, sa.12, ss.5095-5102, 2021 (SCI-Expanded) identifier identifier

37. Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study

KAYA AKCA Ü., BATU AKAL E. D., Kısaarslan A. P., POYRAZOĞLU M. H., Ayaz N. A., Sözeri B., et al.
Lupus , cilt.30, sa.12, ss.1983-1990, 2021 (SCI-Expanded) identifier identifier

38. Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean

ÖZSÜREKCİ Y., Gürlevik S., KESİCİ S., KAYA AKCA Ü., Oygar P. D., Aykac K., et al.
Clinical Rheumatology , cilt.40, sa.8, ss.3227-3237, 2021 (SCI-Expanded) identifier identifier

39. The role of vascular inflammation markers in deficiency of adenosine deaminase 2

KAYA AKCA Ü., SAĞ E., Unal S., Kasap Cuceoglu M., BİLGİNER Y., ÖZEN S.
Seminars in Arthritis and Rheumatism , cilt.51, sa.4, ss.839-844, 2021 (SCI-Expanded) identifier identifier

40. The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic lupus erythematosus

BATU AKAL E. D., KAYA AKCA Ü., PAÇ KISAARSLAN A., SAĞ E., Demir F., DEMİR S., et al.
Journal of Rheumatology , cilt.48, sa.6, ss.907-914, 2021 (SCI-Expanded) identifier identifier

41. Systematic review of childhood-onset polyarteritis nodosa and DADA2

Kasap Cuceoglu M., Sener S., BATU AKAL E. D., KAYA AKCA Ü., DEMİR S., SAĞ E., et al.
Seminars in Arthritis and Rheumatism , cilt.51, sa.3, ss.559-564, 2021 (SCI-Expanded) identifier identifier

42. Penile involvement of immunoglobulin a vasculitis/Henoch-Schönlein purpura

KAYA AKCA Ü., BATU AKAL E. D., Serin O., Ipek O. F., Aydin O., TEKŞAM Ö., et al.
Journal of Pediatric Urology , cilt.17, sa.3, 2021 (SCI-Expanded) identifier identifier

43. Plasma checkpoint protein levels and galectin-9 in juvenile systemic lupus erythematosus

Yuksel K., SAĞ E., DEMİR S., Özdel S., Kaya Ü., Atalay E., et al.
Lupus , cilt.30, sa.6, ss.998-1004, 2021 (SCI-Expanded) identifier identifier

44. A case report of intracranial hypertension and aseptic meningitis: Anti-tumor necrosis factor associated or juvenile idiopathic arthritis related

KAYA AKCA Ü., Sökmen O., BÖLEK E. Ç., DEMİR S., KILIÇ L., Çevik I. Ü., et al.
Turkish Journal of Pediatrics , cilt.63, sa.3, ss.522-526, 2021 (SCI-Expanded) identifier identifier identifier

45. Genetic disorders with symptoms mimicking rheumatologic diseases: A single-center retrospective study

KAYA AKCA Ü., ŞİMŞEK KİPER P. Ö., ÜREL DEMİR G., SAĞ E., Atalay E., ÜTİNE G. E., et al.
European Journal of Medical Genetics , cilt.64, sa.4, 2021 (SCI-Expanded) identifier identifier

46. Performances of the “MS-score” And “HScore” in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients

SAĞ E., Keskin A., Atalay E., DEMİR S., Cuceoglu M. K., KAYA AKCA Ü., et al.
Rheumatology International , cilt.41, sa.1, ss.87-93, 2021 (SCI-Expanded) identifier identifier

47. Is Takayasu’s arteritis more severe in children?

BÖLEK E. Ç., KAYA AKCA Ü., Sari A., SAĞ E., DEMİR S., KILIÇ L., et al.
Clinical and Experimental Rheumatology , cilt.39, sa.2, 2021 (SCI-Expanded) identifier identifier

48. Kawasaki-like disease in children with COVID-19

KAYA AKCA Ü., KESİCİ S., ÖZSÜREKCİ Y., AYKAN H. H., BATU AKAL E. D., Atalay E., et al.
Rheumatology International , cilt.40, sa.12, ss.2105-2115, 2020 (SCI-Expanded) identifier identifier

49. Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: Real life data from the HELIOS registry

SAĞ E., Akal F., Atalay E., KAYA AKCA Ü., DEMİR S., DEMİREL D., et al.
Rheumatology (United Kingdom) , cilt.59, sa.11, ss.3324-3329, 2020 (SCI-Expanded) identifier identifier

50. Comorbidities in familial Mediterranean fever: Analysis of 2000 genetically confirmed patients

Balcl-Peynircioǧlu B., KAYA AKCA Ü., Arlcl Z. S., Avcl E., AKKAYA ULUM Z. Y., KARADAĞ Ö., et al.
Rheumatology (United Kingdom) , cilt.59, sa.6, ss.1372-1380, 2020 (SCI-Expanded) identifier identifier

51. Comorbidities of antiphospholipid syndrome and systemic lupus erythematosus in children

KAYA AKCA Ü., Ayaz N. A.
Current Rheumatology Reports , cilt.22, sa.6, 2020 (SCI-Expanded) identifier identifier

52. Performance of the new ‘Eurofever/PRINTO classification criteria’ in FMF patients

SAĞ E., DEMİREL D., DEMİR S., Atalay E., KAYA AKCA Ü., BİLGİNER Y., et al.
Seminars in Arthritis and Rheumatism , cilt.50, sa.1, ss.172-175, 2020 (SCI-Expanded) identifier identifier

53. The challenge of treating pulmonary vasculitis in Behçet disease: Two pediatric cases

DEMİR S., SAĞ E., KAYA AKCA Ü., HAZIROLAN T., BİLGİNER Y., ÖZEN S.
Pediatrics , cilt.144, sa.2, 2019 (SCI-Expanded) identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. Van der Woude sendromlu iki aile sunumu

GÜZEL NUR B., KAYA AKÇA Ü., MIHÇI E.
59. Türkiye Milli Pediatri Kongresi, Antalya, Türkiye, 4 - 08 Kasım 2015, ss.34, (Tam Metin Bildiri)
Metrikler

Yayın

54

Yayın (Scopus)

51

Atıf (Scopus)

527

H-İndeks (Scopus)

13

Proje

1

Açık Erişim

2